Mu X - Search Results

1

Prognostic value of ephrin B receptors in breast cancer: An online survival analysis using the microarray data of 3,554 patients.

Mu X, Huang O, Jiang M, Xie Z, Chen D, Zhang X. Mu X, et al. Oncol Lett. 2019 Jul;18(1):742-750. doi: 10.3892/ol.2019.10363. Epub 2019 May 17. Oncol Lett. 2019. PMID: 31289549 Free PMC article.

2

Luminal breast cancer cell lines overexpressing ZNF703 are resistant to tamoxifen through activation of Akt/mTOR signaling.

Zhang X, Mu X, Huang O, Xie Z, Jiang M, Geng M, Shen K. Zhang X, et al. Among authors: mu x. PLoS One. 2013 Aug 26;8(8):e72053. doi: 10.1371/journal.pone.0072053. eCollection 2013. PLoS One. 2013. PMID: 23991038 Free PMC article.

3

ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis.

Zhang X, Mu X, Huang O, Wang Z, Chen J, Chen D, Wang G. Zhang X, et al. Among authors: mu x. BMC Cancer. 2022 Mar 2;22(1):226. doi: 10.1186/s12885-022-09286-w. BMC Cancer. 2022. PMID: 35236318 Free PMC article.

4

LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression.

Mou K, Zhang X, Mu X, Ge R, Han D, Zhou Y, Wang L. Mou K, et al. Among authors: mu x. Front Oncol. 2019 Jul 3;9:569. doi: 10.3389/fonc.2019.00569. eCollection 2019. Front Oncol. 2019. PMID: 31334110 Free PMC article.

5

Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR‑367/PTEN axis.

Mu X, Mou KH, Ge R, Han D, Zhou Y, Wang LJ. Mu X, et al. Int J Oncol. 2019 Sep;55(3):708-720. doi: 10.3892/ijo.2019.4848. Epub 2019 Jul 25. Int J Oncol. 2019. PMID: 31364744 Free PMC article.

6

[Corrigendum] Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR‑367/PTEN axis.

Mu X, Mou KH, Ge R, Han D, Zhou Y, Wang LJ. Mu X, et al. Int J Oncol. 2022 Jun;60(6):62. doi: 10.3892/ijo.2022.5352. Epub 2022 Apr 13. Int J Oncol. 2022. PMID: 35417032 Free PMC article.

7

lncRNA-ATB functions as a competing endogenous RNA to promote YAP1 by sponging miR-590-5p in malignant melanoma.

Mou K, Liu B, Ding M, Mu X, Han D, Zhou Y, Wang LJ. Mou K, et al. Among authors: mu x. Int J Oncol. 2018 Sep;53(3):1094-1104. doi: 10.3892/ijo.2018.4454. Epub 2018 Jun 25. Int J Oncol. 2018. PMID: 29956757 Free PMC article.

8

Corrigendum: LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression.

Mou K, Zhang X, Mu X, Ge R, Han D, Zhou Y, Wang LJ. Mou K, et al. Among authors: mu x. Front Oncol. 2022 May 10;12:905360. doi: 10.3389/fonc.2022.905360. eCollection 2022. Front Oncol. 2022. PMID: 35619916 Free PMC article.

9

PARP1 Is a Prognostic Marker and Targets NFATc2 to Promote Carcinogenesis in Melanoma.

Mou K, Zhou Y, Mu X, Zhang J, Wang L, Ge R. Mou K, et al. Among authors: mu x. Genet Test Mol Biomarkers. 2022 Nov;26(11):503-511. doi: 10.1089/gtmb.2021.0214. Epub 2022 Nov 17. Genet Test Mol Biomarkers. 2022. PMID: 36394458

10

miR‑590‑5p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression.

Mou K, Ding M, Han D, Zhou Y, Mu X, Liu W, Wang L. Mou K, et al. Among authors: mu x. Oncol Rep. 2018 Oct;40(4):2056-2066. doi: 10.3892/or.2018.6633. Epub 2018 Aug 7. Oncol Rep. 2018. PMID: 30106445 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,802 results

Search Page

Filters